ORMP
Oramed Pharmaceuticals
$4.16
$0.00 (0%)Oct 28, 2026
Key metrics
The numbers that frame ORMP today
- Market cap
- $173.04M
- P/E (TTM)
- 1.0
- ROIC
- 50.7%
- Div yield
- 6.01%
- Debt / equity
- 0.0
- 52wk Low
- $1.96
- 52wk High
- $5.47
Growth
Revenue and earnings trend for ORMP
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ORMP
Is Oramed Pharmaceuticals a good buy?
Hold. Oramed Pharmaceuticals has excellent momentum, but poor quality makes the setup mixed. Growth looks excellent, which supports the long-term business case, but quality and momentum do not clear the bar together. We think Oramed Pharmaceuticals is selling at a fair price.
What is the market capitalization of ORMP?
Oramed Pharmaceuticals's market capitalization is $173.04M.
What is the P/E (TTM) ratio for ORMP stock?
Oramed Pharmaceuticals's P/E (TTM) ratio is 1, based on trailing earnings.
What is the 52-week high for ORMP stock?
The 52-week high for Oramed Pharmaceuticals is $5.47. The current close of $4.16 is 23.9% below that high.
What is the 52-week low for ORMP stock?
The 52-week low for Oramed Pharmaceuticals is $1.96. The current close of $4.16 is 112.5% above that low.
Does ORMP stock pay dividends?
Oramed Pharmaceuticals pays a dividend. The latest dividend per share in the company data is $0.25, which implies a yield of 6.01% based on the current close.
What is the Debt / Equity ratio for ORMP?
Oramed Pharmaceuticals's Debt / Equity ratio is 0.